Reviva Pharmaceuticals Holdings, Inc. Class of Warrant or Right, Outstanding
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Class of Warrant or Right, Outstanding of 17.58 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-12
- 2026-06-30: Class of Warrant or Right, Outstanding 17.58M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 19.08M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 5.44M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 135.53M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 17.58M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 19.08M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 5.44M shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 135.53M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 81.65M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 47.59M shares 10-Q · filed 2025-05-15 | |
| 2025-01-01 | 47.75M shares 10-Q · filed 2025-11-13 | |
| 2024-12-31 | 2.39M shares 10-K · filed 2026-03-30 | 47.75M shares 10-K · filed 2025-04-03 |
| 2024-09-30 | 33.10M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 26.97M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 25.07M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 22.85M shares 10-K · filed 2025-04-03 | 25.07M shares 10-K · filed 2024-04-15 |
| 2022-12-31 | 18.62M shares 10-K · filed 2025-04-03 | 20.91M shares 10-K · filed 2024-04-15 |
| 2021-12-31 | 16.17M shares 10-K · filed 2024-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |